Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mathew I, Milowski"'
Autor:
Shankar, Vallabhajosula, Stanley J, Goldsmith, Klaus A, Hamacher, Lale, Kostakoglu, Shota, Konishi, Mathew I, Milowski, David M, Nanus, Neil H, Bander
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 46(5)
In radioimmunotherapy, myelotoxicity due to bone marrow radiation-absorbed dose is the predominant factor and frequently is the dose-limiting factor that determines the maximum tolerated dose (MTD). With (90)Y- and (131)I-labeled monoclonal antibodie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a4912c95ce32cda15ba035cf9715cc57
https://pubmed.ncbi.nlm.nih.gov/15872360
https://pubmed.ncbi.nlm.nih.gov/15872360
Autor:
Shankar, Vallabhajosula, Ichei, Kuji, Klaus A, Hamacher, Shota, Konishi, Lale, Kostakoglu, Paresh A, Kothari, Mathew I, Milowski, David M, Nanus, Neil H, Bander, Stanley J, Goldsmith
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 46(4)
111In-Labeled antibodies and peptides have been routinely used as chemical and biologic surrogates for 90Y-labeled therapeutic agents. However, recent studies have shown that there are significant differences in biodistribution between 111In- and 90Y
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f6d6ae05b7c4fa889f64dcb426143dbe
https://pubmed.ncbi.nlm.nih.gov/15809486
https://pubmed.ncbi.nlm.nih.gov/15809486
Autor:
Vallabhajosula, Shankar, Goldsmith, Stanley J., Hamacher, Klaus A., Kostakoglu, Lale, Konishi, Shota, Milowski, Mathew I., Nanus, David M., Bander, Neil H.
Publikováno v:
Journal of Nuclear Medicine; May2005, Vol. 46 Issue 5, p850-858, 9p, 5 Charts, 5 Graphs